Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.

Abstract

Genetic studies have provided increasing evidence that ceramide homeostasis plays a role in neurodegenerative diseases including Parkinson’s disease (PD). It is known that the relative amounts of different ceramide molecular species, as defined by their fatty acyl chain length, regulate ceramide function in lipid membranes and in signaling pathways. In the… (More)

Topics

Cite this paper

@article{Abbott2014AlteredCA, title={Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.}, author={Sarah K. Abbott and Hongyun Li and Sonia Sanz Mu{\~n}oz and Bianca Knoch and Marijka J. Batterham and Karen E. Murphy and Glenda M Halliday and Brett W Garner}, journal={Movement disorders : official journal of the Movement Disorder Society}, year={2014}, volume={29 4}, pages={518-26} }